Anywhere Dx

Anywhere Dx

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $18M

Overview

Anywhere Dx is an early-stage, private diagnostics company building a consumer-centric, disposable diagnostic device to deliver real-time, lab-quality results outside traditional healthcare settings. Led by a team with deep expertise in entrepreneurship, epidemiology, and assay development, the company targets the significant market need for decentralized, scalable, and affordable testing. While still in development and likely pre-revenue, its value proposition lies in disrupting the slow and costly conventional diagnostics model by putting testing directly into users' hands. The company's success hinges on successfully developing and validating its platform, navigating regulatory pathways, and achieving commercial scale against established competitors.

Infectious Disease

Technology Platform

A fully disposable, single-use diagnostic device designed for consumer use that delivers real-time, lab-quality results. The platform emphasizes ease of use, affordability, and scalability, and is likely based on advanced molecular assay chemistry adapted for a simple format.

Funding History

2
Total raised:$18M
Series A$15M
Seed$3M

Opportunities

The company targets the large and growing market for decentralized, consumer-accessible diagnostics, driven by trends in home testing, digital health, and global health equity.
Success could enable scalable testing for public health initiatives and empower individuals with direct access to lab-quality health information.

Risk Factors

Key risks include the significant technical challenge of developing a reliable, low-cost, disposable device with lab-quality performance, navigating complex regulatory pathways for a consumer diagnostic, and competing against established diagnostics companies in a crowded market.

Competitive Landscape

Anywhere Dx competes in the broad point-of-care and direct-to-consumer diagnostics market against large incumbents (e.g., Abbott, Roche, QuidelOrtho) and numerous startups developing home-testing and decentralized diagnostic solutions. Its differentiation hinges on achieving a unique combination of disposability, high accuracy, and true ease-of-use.